Apoptotic versus genotoxic potential of anti-tumor agents: A concept of duality in unity

Medical Hypotheses

Volumn 61, Issue 5-6, 2003, Pages 643-650

  Vladan, B ^a,e   Milicevic Z ^b   Biljana, P S ^c   Nedeljkovic Kurepa, A ^d  

^a ICN Galenika Institute   (Yugoslavia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Institute for Cancer Research KBC   (Yugoslavia)

^e ICN Yu   (Yugoslavia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL CYCLE; CELL DAMAGE; CELL SURVIVAL; CYTOTOXICITY; GENETIC RECOMBINATION; GENOTOXICITY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR RESISTANCE;

EID: 0242550995     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00266-4     Document Type: Article

References (43)

1. Hendreson L., Wolfreys, Windbank S. The ability of the comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis 1998; 13: 89-94.
2. Vock E. H., Lutz W. K., Hoffmann H. D., Vamvakas S. Discrimination between genotoxicity and cytotoxicity in the induction of double-strand breaks in cells treated with etopsid, melphalan, cis-platin, potassium canid, Triton X-100 and gamma irradiation. Mut Res 1998; 413: 83-94.
3. Bajic V., Stanimirovic Z., Markovic B. Two in vivo test of a study of 8-Cl-cAMP genotoxicity in mice BALB/c strain. Acta Vet 2000; 55: 177-190.
4. Pedersen-Bjergard, Philip P. Therapy related malignancies: A review. Eur J Haematol 1989; 42: 39-47.
5. Hartwell L. H., Kastan M. B. Cell cycle control and cancer. Science 1994; 266: 1821-1827.
6. Ashby J. Genetic toxicity in relation to receptor-mediated carcinogenesis. Mut Res 1995; 333: 209-213.
7. Vogel E. W., Nivard M. J. A novel method for parallel monitoring of mitotic recombination and clastogenicity in somatic cells in vivo. Mut Res 1999; 431: 143-153.
8. Guchlear H. J., Vermes A., Vermes I., Haanen C. Apoptosis: molecular mechanisms and implications for cancer therapy. Pharm World Sci 1997; 19(3): 119-125.
9. Hupertz B., Frank H. G., Kaufmann P. The apoptosis cascade - morphological and immunohistochemical methods for its visualization. Anat Embryol 1999; 20: 1-18.
10. Wyllie A. H., Belamy C. O. C., Bubb V. J., Clarke A. R., Corbet S., Curtis L., Harrison D. J., Hooper M. L., Toft N., Webb S., Bird C. C. Apoptosis and carcinogenesis. Brit J Cancer Res 1999; 80: 34-37.
11. Bonni A., Brunet A., West A., Datta S. R., Greenberg M. E. Cell survival promoted by Ras MAP signaling pathway by transcription-dependent and independent mechanisms. Science 1999; 286: 1358-1361.
12. Sanches-Prieto R., Rojas J. M., Taya Y., gutkind J. S. et al. The role for the p38 mitogen activated protein kinase pathway in the transcription activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res 2000; 60(9): 2464-2472.
13. Craig Bennett, Joyce R., Resnik M. A. A persistent doublestrand break destabilizes human DNA in yeast and can lead to G2 arrest and lethality. Cancer Res 1997; 57: 1970-1980.
14. Gupat P., Kamrik S., Shao C., O'Neill P. J., Hunter T. C., Tishfield J. A. High frequency in VIVO loss of heterozygosity is primarily a consequence of mitotic recombination. Cancer Res 1997; 57: 1188-1194.
15. Yuan R. Q., Fan J. A., Ma Y. X. Coordinate alterations in the expression of BRCA 1, BRCA 2, p300 and RAD51 in response to genotoxic and other stresses in human prostate cancer cells. Prostate 1999; 40: 37-49.
16. Raderschall E., Bazarov A., Cao J. et al. Formation of higher-order nuclear Rad structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J Cell Sci 2002; 115: 153-164.
17. Shao N., Chai Y. L., Shyam E., Reddy P., Rao V. N. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 1996; 13: 1-7.
18. Kim C. B., Bubley G. J., Fink D., Howell S. B., Chriten R. D. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin. Br Cancer 1999; 80: 699-704.
19. Vaisman A., Varchenko M., Umar A., Chaney S. G. The role of hMLH1, hMSH3, and HMSH6 defects in cis-platin and oxaplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Canc Res 1998; 16: 3579-3585.
20. He Q., Liang C. H., Lippard S. J. Steroid hormones induce HMG1 over expression and sensitize breast cancer cells to cis-platin and carboplatin. Proc Natl Acad Sci USA 2000; 97(11): 5768-5772.
21. Wunderlich V., Botter M. High-mobility-group proteins and cancer - a emerging link. J Cancer Res Clin Oncol 1997; 123: 133-140.
22. Zdraveski, Melloow J. A., Marinus M. G. et al. Multiple pathways of recombination define cellular responses to cis-platin. Mut Res 1999; 431: 135-140.
23. Jolly C., Morimoto R. I. Role of heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000; 92: 1564-1572.
24. Helmbrecht K., Zeise E., Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif 2000; 33: 341-365.
25. Jaattela M., Wissing D., Kokholm K., Kallunki T., Egeblad M. HSP 70 exerts its anti-apoptotic function downstream of caspase-3 like proteases. EMBO J 1998; 17: 6124-6134.
26. Beere H. M., Wolf B. B., Cain K., Mosser D. D., Majboubi A., Kuwana T., Tailor P., Morimoto R. I., Cohen G. M., Gren D. B. Heat shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000;(2): 469-475.
27. Li C. Y., Lee J. S., Ko Y. G., Kim Ji, Seo J. S. Heat shock protein 70 inhibits apoptosis downstream to citochrome c release and upstream caspase-3 activation. J Biol Chem 2000; 275: 25665-25671.
28. Mosser D. D., Caron A. W., Bourget L., Meriin A. B., Sherman M. Y., Morimoto R. I., Massie B. The chaperone function of HSP-70 is required for protection against stress-induced apoptosis. Mol Cell Biol 2000; 20: 7146-7159.
29. Nylandsted J., Rahde M., Brand K., Bastholm L., Elling F., Jaattela M. Selective depletion of Heat shock protein 70 (HSP 70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000; 97: 7871-7876.
30. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S. M., Kumar V., Weichselbaum R., Nalin C., Alnemri E. S., Kufe D., Kharbanda S. Negative regulation of cytochrome C-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat-shock protein 90. EMBO J 2000; 19(16): 4310-4322.
31. Ivana Sunjarevic. Isolation and characterization of RAD 52 gene locus in mice. Doctoral Thesis. Faculty of Biological Science. University of Belgrade, 1997.
32. Scully R., Chen J., Weaver D. et al. Association of BRCA 1 with Rad 51 in meiotic and meiotic cells. Cell 1997; 88: 265-275.
33. Bauman P., West S. C. Role of the human RAD51 protein in homologous recombination and double-strand break repair. Trends Biochem Sci 1998; 23: 247-251.
34. Papazisis K. T. Cell cycle and cancer. Ann Acad Stud 2000; 3: 62-65.
35. Chen G., Yuan S. F., Liu W., Xu Y. et al. Radiation-induced assembly of Rad 51 and Rad 52 Recombination complex requires ATM and c-Abl. J Biol Chem 1999; 274(18): 12748-12752.
36. Zhang H. B., Tombline G., Weber B. L. BRCA1 andBRCA 2 and damage response: collision and collsion. Cell 1998; 92: 433-436.
37. Yamamoto A., Taki T., Yagi H., Yoshida K., Yoshimmura Y., Nishimune Y., Morita T. Molecular genetic cell cycle-depedent expression of the mouse Rad 51 gene in proliferating cells. Genetics 1996; 251: 1-12.
38. Raicevic L., Radulovic S. Breast cancer susceptibility gene 1-BRCA 1. Arch Oncol 2000; 8(1): 21-23.
39. Schmutte C., Tombline G., Rheim K., Sadoff M. M., Fishel R. Characterization of human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity. Cancer Res 1999; 59: 4564-4569.
40. Judson P. L., Watson J. M., Fowler W. C., Haskill J. S. cis-platin inhibits pacitaxel-induced apoptosis in cis-platin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. Cancer Res 1999; 59: 2425-2432.
41. Hoffmann J. S., Locker D., Villani G., Leng M. HMG1 protein inhibits the translesion synthesis of the major DNA cis-platin adduct by cell extracts. J Mol Biol 1997; 270(4): 539-543.
42. Saintigny Y., Dumay A., Lambert S., Lopez B. S. A novel role for the Bcl-2 protein family: specific suppression of the Rad 51 recombination pathway. EMBO J 2001; 20(10): 2596-2607.
43. Tutt A., Bertwistle, Valentine J. et al. Mutation in Brca 2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J 2001; 20(17): 4704-4716.